Article Details
Retrieved on: 2021-05-17 14:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
So a surprise finding from the ACC meeting today was that a therapy marketed for idiopathic pulmonary fibrosis, Roche's Esbriet, has shown promise ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here